Picture of RetinalGenix Technologies logo

RTGN RetinalGenix Technologies Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for RetinalGenix Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.806-2.08-2.18-3.91-2.09
Depreciation
Non-Cash Items0.6440.5780.8563.481.33
Other Non-Cash Items
Changes in Working Capital0.0050.0770.1560.230.413
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.157-1.42-1.17-0.199-0.348
Capital Expenditures-00
Purchase of Fixed Assets
Cash from Investing Activities-00
Financing Cash Flow Items0.025-0.02500.1090.348
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.2111.371.170.1950.348
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.054-0.0520.003-0.005-0